Do you exercise regularly? Are you between 18-35 years old? If so, you may be eligible to participate in a research study examining how the brain, eyes, and heart work together to maintain balance. Compensation provided.

Are you a nurse in Saudi Arabia? We want to hear from you! Join our UNC study to share your thoughts on using genetics in nursing. Your feedback will help shape better nursing education and support your daily work.

This research study (IRB # 24-3153) involves completing an attention task on the computer with an EEG cap on your head. The attention task itself will take 50 minutes. The whole study (questionnaires, EEG setup, and study conclusion) will take two hours. This study aims to explore aspects of attention and to understand what happens in the brain when attention stays on something. Participants who have completed the study will earn $20 for their participation.

Do you suffer from migraines? Are you interested in helping with migraine research?

The purpose of this immunotherapy study is to compare two different chemotherapy treatments administered before breast cancer surgery to see which has the better outcome.

Do you have a blood cancer or have received a stem cell transplant and have been diagnosed with a respiratory infection? If so, you might be eligible to take part in a study to see if an experimental treatment is effective at reducing the severity of the respiratory infection.

Do you have Acute Myeloid Leukemia (AML) and want to try a new study drug that might help treat your cancer?

An important goal of this study is to evaluate the length of time cancer is not growing or spreading in participants when treated with zanzalintinib compared to everolimus. In addition, this study will also evaluate if zanzalintinib can shrink tumors and help participants live longer as compared to everolimus. This information will help researchers learn if zanzalintinib can be used to treat neuroendocrine cancer.

We are enrolling participants in a research study focused on a new treatments for food allergy. If you or your child have a diagnosed egg, milk or peanut allegry, you may be eligible to take part. This is a unique opportunity to help advance care and contribute to future therapies. Participation is voluntary, and all study-related care is provided at no cost. Contact us to learn more.

The goal of this research study is to test a new study treatment for a specific type of stomach cancer. It is focused on people whose tumors are CLDN18.2 positive, PD-L1 positive, and HER2 negative. This new study treatment has 3 parts: 1. A study drug called zolbetuximab 2. Another study drug called pembrolizumab 3. Standard chemotherapy (mFOLFOX or CAPOX) Researchers want to know if this combination is safe and if it works better than current treatments for people living with this specific type of stomach cancer